A proliferative response was observed against full-length recombinant hPPI in HLA-DQ8 T1D patients (p ≤ 0.04) and in HLA-DQ2/DQ8 T1D patients (p ≤ 0.003) as compared with controls (Figure 5B). Here, ALPL is linked to type 1 diabetes mellitus.